本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Clearmind Medicine, Inc.

1.17
-0.0700-5.65%
盤後1.220.0542+4.63%19:59 EST
成交量:1.66萬
成交額:1.97萬
市值:175.48萬
市盈率:-0.04
高:1.23
開:1.23
低:1.15
收:1.24
52周最高:53.70
52周最低:1.05
股本:149.98萬
流通股本:124.85萬
量比:0.29
換手率:1.33%
股息:- -
股息率:- -
每股收益(TTM):-30.3500
每股收益(LYR):-30.3477
淨資產收益率:-179.39%
總資產收益率:-53.11%
市淨率:1.47
市盈率(LYR):-0.04

資料載入中...

2026/01/20

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/12/05

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/11/27

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/10/01

SEC問詢函

Form CORRESP - Correspondence
2025/09/19

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/01/22

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/12/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/03/27

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/03/19

SEC問詢函

Form CORRESP - Correspondence
2024/03/18

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/02/14

SEC問詢函

Form CORRESP - Correspondence
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/07

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/02/06

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/29

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/01/22

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/27

SEC問詢函

Form CORRESP - Correspondence
2023/09/14

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/09/13

SEC問詢函

Form CORRESP - Correspondence